S100A8 and neoplasm: In vivo, these interactions, occurring at the tumor stroma interface, probably contribute in the balance between the reported pro- and anti-tumor effects of S100A8/A9 in PDAC and further investigations of this phenomenon might allow the identification of new potential targets for intervention.